Records containing: Multiple Sclerosis, Relapsing-Remitting
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-09-06The Relationships Between Personal Identity, Autobiographical Memory and Future Thinking in People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2023-09-05PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.
-
CLINICAL_TRIALS study record update · 2023-08-01Study on the Dimethyl Fumarate (DMF, Tecfidera®) Persistence of Remitting-relapsing Multiple Sclerosis (RR-MS) Patients Included in the French Patient Support Program (PSP) OroSEP
-
CLINICAL_TRIALS study record update · 2023-07-07Tolerance-Induction With Dendritic Cells Treated With Vitamin-D3 and Loaded With Myelin Peptides, in Multiple Sclerosis Patients (TOLERVIT-MS)
-
CLINICAL_TRIALS study record update · 2023-05-16A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Arm, Parallel Group Study in Pediatric Subjects Aged 10 Through 17 Years to Evaluate the Efficacy and Safety of BG00012 and BIIB017 for the Treatment of Relapsing-Remitting Multiple Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-04-28Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2023-04-18Non-interventional Safety Study to Investigate Pregnancy Outcomes in Female Patients Exposed to SC Peginterferon Beta-1a and IM Interferon Beta-1a Reported in a German Patient Support Program
-
CLINICAL_TRIALS study record update · 2023-04-12Assessment of a Clinical Decision Support System (CADIMS) for Improving Multiple Sclerosis Diagnostic Accuracy
-
CLINICAL_TRIALS study record update · 2023-03-10Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2023-03-09Effect of Bio-electromagnetic Energy Regulation Therapy on Erectile Dysfunction in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2023-03-08Everyday Life Cognition and Non-conventional Magnetic Resonance Markers in RRMS Patients Treated With Aubagio® in a Real-life Setting
-
CLINICAL_TRIALS study record update · 2023-03-02The Relation Between Physical Activity, Sedentary Behaviour, and Cardiometabolic Health in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2023-02-08Impact of a Multimedia Website With Patient Experiences of Multiple Sclerosis (PExMS) on Immunotherapy Decision-making: a Pilot Randomised Controlled Trial in a Mixed-methods Design
-
CLINICAL_TRIALS study record update · 2023-01-13Assessment of Deep Gray Matter Anatomic Changes in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With Gilenya® (Fingolimod) With and Without Cognitive Impairment Over a 2 Year Period Using 3 Dimensional Volumetric MRI Studies (NeuroQuant, NeuroQuarc) and Automated Neuropsychological Assessment Matrices (ANAM)
-
CLINICAL_TRIALS study record update · 2022-11-15Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-09-16Imaging of Intracerebral Inflammation in the Progressive Phase of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-08-17Cellular microRNA Signatures in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-06-30Factors Affecting Time Elapsed From First Symptom Till Complete Diagnosis of Multiple Sclerosis, Initiation of Disease Modifying Treatment and Drug Adherence in Upper Egypt
-
CLINICAL_TRIALS study record update · 2022-06-06Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis: a Novel, Advanced Multimodal MRI and Optical Coherence Tomography-Angiography (OCTA) Study
-
CLINICAL_TRIALS study record update · 2022-04-28Efficacy, Safety and Cost-effectiveness of B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-04-22Investigating the Effects of Hydroxyvitamin D3 Versus Vitamin D3 on Clinical, and Radiologic Progress and Th17/Tregs Balance in MS Patients: A Randomized, Clinical Trial- a Pilot Study
-
CLINICAL_TRIALS study record update · 2022-03-09Real World Effectiveness of Natalizumab Extended Interval Dosing in Relapsing-Remitting Multiple Sclerosis in a French Cohort
-
CLINICAL_TRIALS study record update · 2022-02-01Evaluation of Relapse Presence in Multiple Sclerosis Patients by Cross-Sectional In-Vivo Corneal Confocal Microscopy
-
CLINICAL_TRIALS study record update · 2021-10-26Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential
-
CLINICAL_TRIALS study record update · 2021-10-22Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis